Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dex Surgical is a French medtech company developing robotized and mechatronic laparoscopic instruments intended to improve dexterity, precision, and surgeon ergonomics during minimally invasive surgery. Its core product, the DEX Device, combines articulated distal mobility, an ergonomic control handle, embedded electronics, and reusable instrument arms for dissection, suturing, grasping, and monopolar cautery. The company positions its technology as a lower-complexity alternative to full telesurgical robotic platforms by keeping the surgeon at the patient bedside with haptic interaction. Dex Surgical states that its system is CE marked for Europe and FDA cleared for the U.S. market, indicating commercial-stage activity in surgical devices rather than therapeutic drug development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dex Surgical.